| Scope of Activity: | Company Management: Determination of the strategy, reporting to & working with the Board of Directors and the shareholders, Management of the operational business. Reporting line: to the shareholders. |
| Turnover / Budget Responsibility | Start-up- Bioinformatic company, founded in Oktober 1997; 2001: Sales 0,9 Mio. €, Profit -1,2 Mio. €, 30 employees; 2014: Sales 6,5 Mio. €, Profit 1,3 Mio €, 120 employees |
| Projects: | 1) Sale of company to a strategic investor (Qiagen) in April 2014.2) MBO in March 2012, my diluted holding was 40% of shares.3) Increase shareholder value from 2012 to 2014 several fold by changing the strategic direction, restructuring and sales growth.
4) Successful closing the second financing round with a strategic Japanese investor and rescuing the company by avoiding bankruptcy, Jan. 2002. 5) Turnaround: Restructuring of the organization, concentration on core competencies in 2002. 6) Identifying, closing of an acquisition double in size to Biobase in the US in Jan. 2005; thereafter restructuring and integrating of the target. 7) Creating an organization in India and transferring processes (currently 90 employees). 8) Closing long-term distribution contracts with for two leading databases which became main generators of growth. 9) Introduction of a cost controlling system, a comprehensive decision oriented reporting system, an own bookkeeping with monthly closings, an annual budgeting and a monthly forecast for the P&L, balance sheet, cash flow statement, personnel development. 10) Delegation of authority: delegation of responsibility, introduction of a middle and project management. 11) Acquisition of government grants totaling > 5 Mio. €, 12) Founding a Japanese subsidiary. |
| Salary: | 128.600 € fix plus annual bonus of 63.100 €, pension scheme of 20.000 € / year, company share (7%), company car |
| Mitarbeiterzahl: | 130 employees |
Position: CFO und CEO
Project details
Company: Biobase GmbH
Timeframe: Oct 2001 to April 2015
